5th Annual Partnerships in Clinical Trials Congress (PCT) and Exhibition

Posted:
15
August 2006

Win a VIP invite to the Partnerships in Clinical Trials congress (PCT), Belgium including:

  • Delegate pass for the duration of the event
  • Travel and accommodation costs

Richmond Pharmacology will be exhibiting at this years PCT congress 13th-15th November 2006, Brussels Expo, Belgium www.ct-partnerships.com.Managing Director Dr Jorg Taubel of Richmond Pharmacology is on the panel of guest speakers and will be covering the topic:'Effective Partnering between Sponsors & Niche Providers'Examining:

  • What niche providers can deliver that global CROs cannot
  • How do partnerships between smaller sponsors & niche providers benefit both
  • The role niche providers play in global clinical trials

If you are planning to attend the conference then please take a look at our prize draw below:We are running a prize draw to win a VIP invite to the PCT event which includes:

  • Delegate pass for 2 days for 1 guest
  • Travel and accommodation costs for the duration of the event for 1 guest

To attend the conference as a guest of Richmond Pharmacology why not enter the prize draw below to be in with a chance to win.To enter, click here

Latest news

Upcoming Event

The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

4 – 5 December 2020
The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development.
View event

Contributing to our community in 2020

December 17, 2020
Richmond Pharmacology has a long-standing tradition of supporting local, national, and international charities and 2020 is no exception.
Read more

Richmond Pharmacology supports Cardior Pharmaceuticals with the pioneering trial of an oligonucleotide-based drug in heart failure patients

December 14, 2020
Richmond Pharmacology is delighted to welcome the positive Phase Ib results of Cardior Pharmaceuticals lead compound CDR132L for heart failure.
Read more

Marking a milestone for gene editing

November 10, 2020
We are pleased to share that Richmond Pharmacology, in partnership with Intellia Therapeutics and the Royal Free Hospital, have treated the first patient in a landmark CRISPR/Cas9 clinical trial of NTLA-2001
Read more